| Ticker: IMRI | 8326 Melrose Drive | |
| Exchange: NASDAQ-National Market | Lenexa, Kansas 66214 | |
| Industry: Service | (913) 894-0591 |
| Type of Shares: | Common Shares | Filing Date: | 8/12/96 | |
| U.S. Shares: | 2,500,000 | Offer Date: | 11/6/96 | |
| Non-U.S. Shares: | 0 | Filing Price: | - | |
| Primary Shares: | 2,500,000 | Offer Price: | $6.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.42 | |
| Offering Amount: | $34,500,000 | Selling: | $0.23 | |
| Expenses: | $700,000 | Reallowance: | $0.10 | |
| Shares Out After: | 6,717,517 |
| Manager | Tier | Phone |
| Hambrecht & Quist Incorporated | Lead Manager | (415) 576-3423 |
| Invemed Associates Inc. | Co-manager | (212) 421-2500 |
| Piper Jaffray Incorporated | Co-manager | (612) 342-6000 |
| Auditor: Ernst & Young | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 9/30/96 | 9/30/95 | 9/30/96 | ||
| Revenue: | $7.22 | $8.06 | $4.96 | Assets: | $7.62 |
| Net Income: | -$1.15 | -$2.93 | -$1.16 | Liabilities: | $6.38 |
| EPS: | -$0.38 | -$0.69 | Equity: | $1.25 | |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is the leading provider of disease management services for men suffering from sexual dysfunction, focusing primarily on the diagnosis and treatment of erectile dysfunction, commonly known as impotence. The company provides comprehensive diagnostic, educational and treatment services designed to address the medical and emotional needs of its patients and their partners through the largest network of medical clinics in the United States dedicated to the diagnosis and treatment of impotence. The company believes that this market is largely underserved due to misconceptions about the causes of impotence, the general lack of specialized knowledge by primary care physicians about treatment alternatives and the limited focus on impotence by medical specialists. The company utilizes a direct marketing approach designed to motivate impotent men to seek treatment and to educate them, their partners and other physicians about available and affordable treatment options. The company currently operates 29 Centers in 18 states and has one additional Center under development scheduled to open by the end of 1996. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to develop additional facilities, to repay debt, for working capital and general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.